Biogen to build blood disorder drug franchise

Links shared publicly online about this topic.

  • 463
    total visits

Biogen to build blood disorder drug franchise

health.yahoo.net

Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.

View full resource at health.yahoo.net

Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Disease and Condition, Drug, Tysabri, Biogen Idec

  • Share

Most Recently Shared on March 4, 2011 at 4:56 pm By:

nutritionbuff Jane Anderson

Correction: Biogen to build blood disorder drug franchise http://bit.ly/gSPmx1

1 year ago...

Biogen scouting for new hematology programs to buy, license - FierceBiotech

fiercebiotech.com — “Biogen Idec's new CEO, George Scangos (photo), is prepared to bring out the company's check book to build up its franchise of new drugs for noncancerous diseases of the blood. The big biotech, which Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on March 7, 2011 at 3:19 pm By:

FierceBiotech FierceBiotech Health News

Biogen scouting for new hematology programs to buy, license. http://bit.ly/fiPc8V

1 year ago...

Biogen to build blood disorder drug franchise | Reuters

reuters.com — “BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 4, 2011 at 5:27 pm By:

Biogen to build blood disorder drug franchise | Reuters

reuters.com — “BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 4, 2011 at 4:58 pm By:

Reuters_Health Reuters Health Health News

Biogen to build blood disorder drug franchise http://is.gd/JG4sYs

1 year ago...

Biogen to build blood disorder drug franchise | Reuters

reuters.com — “BOSTON (Reuters) - Biogen Idec Inc, which makes the multiple sclerosis drugs Tysabri and Avonex, plans to build a portfolio of products to treat noncancerous blood disorders, according to its chief executive.TheView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on March 4, 2011 at 4:55 pm By:

MedicalNews Medical News Health News

Biogen to build blood disorder drug franchise http://bit.ly/hC5Sjp

1 year ago...

Advertisement